통합관점의 기술준비지수와 도입 효과에 관한 연구

Abstract

Korea's The Food and Drug Administration (FDA) authorized digital tablets, which are pharmaceuticals with a sensor that may notify doctors whether or not patients are taking their medication. The purpose of this study is to contribute to the proper usage of digital pills, by highlighting the main ethical and social challenges it raises and providing solutions. The purpose are as follows. (1) to prepare a good perception for users to accept the digital pills revolution that is changing our lives health-wise, (2) to develop, test, and validate TRI and TAM for the adoption of digital pills, (3) to strengthen the user's understanding of the digital pill's adoption and continue to use, this study's methodology is appropriate for gathering data and addressing the research questions via an online survey. The methodologies are conceptually and practically linked with previous research, with the goal of building on them while minimizing the limitations of previous work. The TRI and TAM formulated from the literature review were empirically validated from data acquired in an online survey conducted on Amazon Mechanical Turk. ln total 319, samples were gathered and 310 valid responses were analyzed after eliminating 9 invalid responses. This study used the structural equation modeling technique, which allows for simultaneous analysis. SmartPLS 3.0 and TBM SPSS version 23.0 were used for the analysis. Moreover, this study investigates TRI and TAM, however, the primary purpose is to examine the relationship between antecedents' (TRI) technological readiness index and Adoption Intention. The results of the analyses show that optimism, innovativeness, discomfo1t, and Insecurity have positive impacts on perceived ease of use. The majority of the given hypotheses are supported by a satisfactory overall model fit index. The empirical findings of this study add to our understanding and explanation of the critical mechanism underlying digital pill users' adoption intention decision-making process.